BIOMEDICAL RESEARCH FOUNDATION

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1989

Legal Domicile

Principal Officer

ALAN WOLFMAN

Phone

5012574516

Tax Period

2025-01-01 to 2025-12-31

BIOMEDICAL RESEARCH FOUNDATION, founded in 1989, is a community nonprofit that reported $1.4M in total revenue in fiscal year 2025. Revenue decreased 11% compared to the prior year.

Mission

ADVANCE THE RESEARCH AND EDUCATION MISSION OF THE DEPARTMENT OF VETERANS AFFAIRS BY SUPPORTING RESEARCH RELATED ACTIVITIES AT THE JOHN L. MCCLELLAN MEMORIAL VETERANS HOSPITAL IN LITTLE ROCK, ARKANSAS.

Program Service Accomplishments

Program 1

Expenses: $364,952

DOD: THE PRINCIPAL INVESTIGATORS (PIS) OF THIS APPLICATION PROPOSE TO TEST THE HYPOTHESIS THAT THE SEVERITY OF INDIVIDUAL EXPOSURE TO BURN PITS WILL BE POSITIVELY CORRELATED WITH LEVELS OF PERSISTENT ORGANIC POLLUTANTS IN BLOOD AND METALS IN URINE AND THE NUMBER OF EPIGENETIC ALTERATIONS IN DNA METHYLATION AND THAT LEVELS OF TOXIC CHEMICALS AND ALTERATIONS IN THE METHYLATION OF SPECIFIC GENES WILL BE POSITIVELY CORRELATED WITH CHRONIC PROBLEMS INVOLVING THE CARDIOVASCULAR, RESPIRATORY, NEUROPSYCHIATRIC, AND OTHER ORGAN SYSTEMS. THE PROJECT'S SPECIFIC AIMS ARE TO (1) DESCRIBE AND QUANTIFY RELATIONSHIPS OF INTENSITY AND DURATION OF EXPOSURE WITH PERSISTENT ORGANIC CHEMICALS/METALS IN THE REGISTRY PARTICIPANTS AND ASCERTAIN THEIR RELATIONSHIPS WITH HEALTH OUTCOMES LINKED TO BURN PIT EXPOSURE AND (2) DISCOVER AND VALIDATE DNA METHYLATION MARKS THAT BEST DISTINGUISH BETWEEN INDIVIDUALS EXPOSED TO BURN PITS AND THOSE NOT EXPOSED AND THEN DESCRIBE AND QUANTIFY THE RELATIONSHIPS BETWEEN DNA METHYLATION, INTENSITY AND DURATION OF EXPOSURE, AND HEALTH OUTCOMES

Program 2

Expenses: $110,932

PHASER: MEDICAL TRAINING AND EDUCATION PROGRAM TO SUPPORT THE TRAINING AND EDUCATIONAL COMPONENTS OF THE VA PHARMACOGENOMICS ACTION FOR CANCER SURVIVORSHIP (PHASER) PROGRAM THAT WILL OFFER...

PHASER: MEDICAL TRAINING AND EDUCATION PROGRAM TO SUPPORT THE TRAINING AND EDUCATIONAL COMPONENTS OF THE VA PHARMACOGENOMICS ACTION FOR CANCER SURVIVORSHIP (PHASER) PROGRAM THAT WILL OFFER PHARMACOGENOMIC TESTING TO VETERAN CANCER SURVIVORS RECEIVING MEDICAL CARE THROUGH THE VA.

Program 3

Expenses: $56,956

DEFINE GPS: COLLABORATOR DESIRES VA TO PARTICIPATE IN COLLECTING DATA TO ASSESS THE PERFORMANCE OF COLLABORATOR'S PROPRIETARY IFR CO-REGISTRATION SOLUTION USING COMMERCIALLY AVAILABLE PHILIPS...

DEFINE GPS: COLLABORATOR DESIRES VA TO PARTICIPATE IN COLLECTING DATA TO ASSESS THE PERFORMANCE OF COLLABORATOR'S PROPRIETARY IFR CO-REGISTRATION SOLUTION USING COMMERCIALLY AVAILABLE PHILIPS PRESSURE GUIDEWIRES AND THE PHILIPS SYNCVISION CO-REGISTRATION SYSTEM IN ACCORDANCE WITH DEFINE GPS PROTOCOL REFERENCED ABOVE

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $982,355

Program Service Revenue $313,246

Investment Income $55,187

Other Revenue $0

TOTAL REVENUE $1,350,788

Expense Breakdown

Grants Paid $0

Salaries & Benefits $870,416

Fundraising Expenses $0

Program Expenses $1,110,946

Other Expenses $493,893

TOTAL EXPENSES $1,364,309

Year-over-Year Comparison

	2025	2024	Change
Revenue	$1,350,788	$1,521,830	-0.1%
Expenses	$1,364,309	$1,213,123	+0.1%
Net Income	$-13,521	$308,707	-1.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$634,157

Total Directors

$1,138,598

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SHANNA PALMER	PRESIDENT	1.00	Officer Director	$0	$0	$345,429
RICHARD DENNIS	VICE PRESIDENT	1.00	Officer Director	$0	$0	$143,328
MICHAEL MOORE	DIRECTOR	1.00	Director	$0	$0	$258,111
JENNIFER ANDERSON	DIRECTOR	1.00	Director	$0	$0	$391,730
TERRY DEWITT	DIRECTOR	1.00	Director	$0	$0	$0
SHUK-MEI HO	DIRECTOR	1.00	Director	$0	$0	$0
MOHAMMED MOURSI	DIRECTOR	1.00	Director	$0	$0	$0
ALAN WOLFMAN	EXECUTIVE DIRECTOR	40.00	Officer	$145,400	$0	$145,400

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$1,350,788	$1,364,309	$2,168,753	$-13,521
2024	No data	No data	No data	No data
2023	$1,680,859	$1,122,288	$1,929,717	$558,571
2022	$1,219,275	$1,281,795	$1,305,966	$-62,520
2021	$1,760,299	$1,259,761	$1,354,663	$500,538
2020	$863,390	$1,311,426	$1,514,720	$-448,036
2019	$1,361,864	$1,040,509	$1,307,812	$321,355
2018	$1,227,685	$1,129,297	$1,012,082	$98,388